07/02/2012

Report no. 68/2012

Amendment to a significant contract in the subsidiary company “Mikulicz” sp. z o.o. in Świebodzice

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A., in connection with receiving as of 2 July 2012 annexes to the  contracts concluded with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) signed by the subsidiary company “Mikulicz” sp. z o.o. ) regarding healthcare services in the scope of outpatient specialist care and outpatient specialist care –cost-consuming outpatient diagnostic services for the period from 1-31 January 2012.

Healthcare services referred to hereinabove are provided by the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice owned by EMC Instytut Medyczny S.A.

The Issuer informed about the contracts concluded by Mikulicz sp. z o.o. with the Fund Branch concerning rendering services in 2012 in its current report nos. 5/2012 of 20.01.2012, 16/2012 of 30.01.2012, 24/2012 of 15.02.2012 and 52/2012 of 31.05.2012.

As a result of signing the said annexes, the total maximum Fund Branch liability towards the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice has changed and  it currently amounts to PLN 13,768,132.70 (an increase by PLN 19,045.70) for the period from 1 January to 31 December 2012.

The other material terms of the contract with the highest value made public remain unchanged.

A criterion for a contract to be considered significant: The value of contracts exceeds 10% of the Issuer’s equity capital.